This information was published on 2026-07-31T10:12:52 for IP Right Registration Published.
| Field | Value |
| (210) | 2627058 (IR 1902571) |
| (220) |
23 Dec 2025
|
| (500) |
The mark consists of five crescent shapes arranged to form a circle, a capsule shape resembling a pill inside the circle, the capsule having a half crescent shape cutting into the capsule, letters forming the phrase "Gyre" with the letter "G" in capital letter situated to the right of the circle, and letters forming the phrase "THERAPEUTICS" situated underneath the phrase "Gyre".
THERAPEUTICS |
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases. Class 42 Conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products development; research and development in the pharmaceutical and biotechnology fields; testing of pharmaceuticals. |
| (540) |
|
| (550) | Figurative |
| (730) |
Gyre Therapeutics, Inc.
|
Find out more about publications on the About page.